AB6DQ43TKE
actinium-225;(2S)-2-[[(1S)-1-carboxylato-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioate;hydron
Molecular Identity
AB6DQ43TKE
actinium-225;(2S)-2-[[(1S)-1-carboxylato-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioate;hydron
PubChem CID: 177897004
2D Structure
Properties
C49H68AcN9O16-3
Molecular Formula
1264.10
Molecular Weight
g/mol
1263.5016
Exact Mass
Da
382
TPSA
May have limited oral absorption
8
H-Bond Donors
20
H-Bond Acceptors
1840
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(11)
AB6DQ43TKEAAA817225Ac-PSMA-617AAA-817Actinium Ac-225 Vipivotide TetraxetanActinium(225Ac) Vipivotide Tetraxetanactinium (225Ac) vipivotide tetraxetanactinium (225Ac) vipivotide tetraxetan [INN]Actinium Ac-225 Vipivotide Tetraxetan Hydrogen (1:3)2247839-17-2Actinate(3-)-225Ac, [N6-[N-[[trans-4-[[[2-[4,7,10-tris[(carboxy-kappaO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-kappaN1,kappaN4,kappaN7,kappaN10]acetyl-kappaO]amino]methyl]cyclohexyl]carbonyl]-3-(2-naphthalenyl)-L-alanyl]-N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-L-lysinato(6-)]-, hydrogen (1:3)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to AB6DQ43TKE
Loading drug network...